NCT05023447

Brief Summary

The BRIDGE project: A feasibility randomised controlled trial of brief, intensive assessment and integrated formulation for young people (age 14-24) early in the course of borderline personality disorder.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 26, 2021

Completed
6 days until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

April 26, 2024

Status Verified

April 1, 2024

Enrollment Period

2.7 years

First QC Date

July 9, 2021

Last Update Submit

April 24, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Recruitment & Retention rates

    The number of participants recruited for randomisation and the number retained to follow-up (12 \& 24wks post randomisation).

    Continuous over 3 year study period

Secondary Outcomes (2)

  • Acceptability of trial processes and interventions

    Continuous over 3 year study period

  • Process Evaluation

    Continuous over 3 year study period

Other Outcomes (14)

  • Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II) PQ-BPD

    Screening; Pre-randomisation

  • Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II) DSM-V

    Screening/Pre-randomisation

  • KIDSCREEN-10 Index

    Screening/Pre-randomisation

  • +11 more other outcomes

Study Arms (2)

BRIDGE Intervention (+Service as Usual)

EXPERIMENTAL

Brief, intensive assessment and integrated formulation (BRIDGE) intervention is guided by the evidence base of Cognitive Analytic Therapy (CAT) with young people (aged 14-25) with features of BPD using an early intervention model and in collaboration with an established Glasgow programme, Intensive Support and Monitoring Service (ISMS). ISMS focuses on reaching a shared formulation with the young person and the multi-agency system that supports them. BRIDGE is delivered over 3-6 months and includes :- an intensive assessment, including BPD symptoms, copresenting difficulties, neurodevelopmental profile, life events history and psychosocial functioning; up to 16 sessions of Cognitive Analytic Therapy (CAT) and the development of a shared formulation with a multi-agency group. Further development of this formulation with the young person, using CAT principles (Reformulation, Recognition and Revision) and, where clinically applicable, their family and service-providers.

Behavioral: BRIDGE InterventionBehavioral: Service as Usual

Service as Usual

ACTIVE COMPARATOR

Services as Usual (SAU) For participants randomised to SAU, a routine letter of their participation will be shared with their service provider(s), including their GP. SAU, is likely to range from social services, mental-health services, forensic services to no services in some cases. Pathways to care and service involvement will be mapped and described for each participant. Treatment fidelity to SAU will therefore not be assessed, but the nature and intensity of SAU in different contexts will be described in detail through the qualitative process evaluation.

Behavioral: Service as Usual

Interventions

Intensive clinical assessment; \>16 sessions of Cognitive Analytic Therapy (CAT); Development of a shared formulation

BRIDGE Intervention (+Service as Usual)

Likely to range from social services, mental-health services, forensic services to no intervention

BRIDGE Intervention (+Service as Usual)Service as Usual

Eligibility Criteria

Age14 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Cut off score of 11 out of 15 on the self-reported SCID-II BPD questionnaire AND subthreshold (3 or 4 out of 9 domains) or threshold (5 and above out of 9 domains) criteria on the SCID-II DSM-V (BPD Module)
  • Age 14-25

You may not qualify if:

  • Currently receiving psychological/counselling /psychotherapeutic treatment for BPD
  • Has received psychological/counselling/psychotherapeutic intervention for over 8 sessions in the last 3 months
  • Severe or profound intellectual disability, that would preclude full engagement in talking therapy
  • Receiving Intensive psychiatric treatment at the time of study entry, for conditions such as acute psychosis or severe eating disorder
  • Non-English speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NHS Greater Glasgow and Clyde Clinical Research and Development Central Office

Paisley, PA2 7DE, United Kingdom

Location

Related Publications (1)

  • Gajwani R, Sim F, McAllister K, Smith H, McIntosh E, Moran P, Ougrin D, Smith M, Gumley AI, Chanen AM, Minnis H. The BRIDGE project: a feasibility randomised controlled trial of brief, intensive assessment and integrated formulation for young people (age 14-24) with features of borderline personality disorder (Protocol). Front Psychiatry. 2024 Sep 24;15:1389578. doi: 10.3389/fpsyt.2024.1389578. eCollection 2024.

MeSH Terms

Conditions

Borderline Personality Disorder

Condition Hierarchy (Ancestors)

Personality DisordersMental Disorders

Study Officials

  • Ruchika Gajwani, Dr

    University of Glasgow

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Randomized
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 9, 2021

First Posted

August 26, 2021

Study Start

September 1, 2021

Primary Completion

April 30, 2024

Study Completion

September 30, 2024

Last Updated

April 26, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

The PI will manage access rights to the data set. We anticipate that anonymised trial data may be shared with other researchers to contribute to the emerging BPD evidence base.

Locations